Change of Registered Office

RNS Number : 0464R
Hemogenyx Pharmaceuticals PLC
01 July 2022
 

1 July 2022  

Hemogenyx Pharmaceuticals plc  

("Hemogenyx Pharmaceuticals" or the "Company")

 

Change of Registered Office

 

Hemogenyx Pharmaceuticals plc announces that its registered office address has changed with immediate effect to 6th Floor,60 Gracechurch Street, London, EC3V 0HR,United Kingdom.

 

 

Enquiries:

 

Hemogenyx Pharmaceuticals plc

https://hemogenyx.com

Dr Vladislav Sandler, Chief Executive Officer & Co-Founder

headquarters@hemogenyx.com

Peter Redmond, Director

peter.redmond@hemogenyx.com





SP Angel Corporate Finance LLP

Tel: +44 (0)20 3470 0470

Matthew Johnson, Vadim Alexandre, Adam Cowl







Peterhouse Capital Limited

Tel: +44 (0)20 7469 0930

Lucy Williams, Duncan Vasey, Charles Goodfellow







 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CROMZGGNMMDGZZM

Companies

Hemogenyx Pharmaceuticals (HEMO)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today